Fingerprint
Dive into the research topics of 'The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically